Lord Abbett & CO. LLC Buys 89,799 Shares of Clorox Company (The) (CLX)

Lord Abbett & CO. LLC lifted its stake in shares of Clorox Company (The) (NYSE:CLX) by 20.3% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 532,617 shares of the company’s stock after purchasing an additional 89,799 shares during the quarter. Lord Abbett & CO. LLC owned about 0.41% of Clorox Company (The) worth $70,966,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently modified their holdings of the stock. Phocas Financial Corp. bought a new stake in Clorox Company (The) in the second quarter worth about $167,000. WFG Advisors LP raised its position in Clorox Company (The) by 7.2% in the second quarter. WFG Advisors LP now owns 1,571 shares of the company’s stock worth $209,000 after acquiring an additional 106 shares in the last quarter. Toronto Dominion Bank raised its position in Clorox Company (The) by 26.0% in the second quarter. Toronto Dominion Bank now owns 43,627 shares of the company’s stock worth $5,811,000 after acquiring an additional 9,009 shares in the last quarter. Cetera Investment Advisers raised its position in Clorox Company (The) by 17.9% in the second quarter. Cetera Investment Advisers now owns 2,627 shares of the company’s stock worth $348,000 after acquiring an additional 399 shares in the last quarter. Finally, Beaton Management Co. Inc. bought a new stake in Clorox Company (The) in the second quarter worth about $320,000. Institutional investors and hedge funds own 71.30% of the company’s stock.

Shares of Clorox Company (NYSE:CLX) traded down 0.41% during midday trading on Friday, hitting $127.34. The company had a trading volume of 372,897 shares. The firm has a market capitalization of $16.44 billion, a P/E ratio of 23.87 and a beta of 0.39. Clorox Company has a 12-month low of $111.24 and a 12-month high of $141.76. The firm’s 50-day moving average is $131.66 and its 200-day moving average is $134.03.

Clorox Company (The) (NYSE:CLX) last posted its earnings results on Thursday, August 3rd. The company reported $1.53 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.49 by $0.04. The firm had revenue of $1.65 billion for the quarter, compared to the consensus estimate of $1.65 billion. Clorox Company (The) had a return on equity of 190.67% and a net margin of 11.74%. The business’s quarterly revenue was up 2.9% on a year-over-year basis. During the same quarter in the prior year, the business posted $1.30 earnings per share. On average, analysts predict that Clorox Company will post $5.64 earnings per share for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Monday, November 13th. Shareholders of record on Wednesday, October 25th will be given a dividend of $0.84 per share. The ex-dividend date is Tuesday, October 24th. This represents a $3.36 annualized dividend and a dividend yield of 2.63%. Clorox Company (The)’s dividend payout ratio is currently 63.04%.

Several brokerages have commented on CLX. Jefferies Group LLC reiterated a “hold” rating and issued a $137.00 price target (up from $136.00) on shares of Clorox Company (The) in a research report on Wednesday, August 9th. Royal Bank Of Canada reissued a “hold” rating and issued a $115.00 price target on shares of Clorox Company (The) in a research note on Wednesday, August 2nd. BMO Capital Markets set a $150.00 price target on Clorox Company (The) and gave the stock a “buy” rating in a research note on Thursday, August 3rd. BidaskClub raised Clorox Company (The) from a “strong sell” rating to a “sell” rating in a research note on Monday, July 31st. Finally, Zacks Investment Research cut Clorox Company (The) from a “buy” rating to a “hold” rating in a research note on Monday, July 31st. Three analysts have rated the stock with a sell rating, nine have given a hold rating and two have assigned a buy rating to the stock. Clorox Company (The) presently has a consensus rating of “Hold” and a consensus target price of $127.39.

In related news, COO Dawn C. Willoughby sold 2,158 shares of the stock in a transaction on Tuesday, August 29th. The stock was sold at an average price of $138.00, for a total value of $297,804.00. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, EVP James E. Foster sold 9,861 shares of the stock in a transaction on Wednesday, August 23rd. The stock was sold at an average price of $138.51, for a total value of $1,365,847.11. Following the completion of the sale, the executive vice president now owns 22,069 shares in the company, valued at approximately $3,056,777.19. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 21,242 shares of company stock worth $2,944,449. Company insiders own 1.00% of the company’s stock.

TRADEMARK VIOLATION WARNING: “Lord Abbett & CO. LLC Buys 89,799 Shares of Clorox Company (The) (CLX)” was posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this news story on another domain, it was stolen and republished in violation of US and international copyright laws. The correct version of this news story can be accessed at https://www.dispatchtribunal.com/2017/10/27/lord-abbett-co-llc-has-70-97-million-position-in-clorox-company-the-clx.html.

Clorox Company (The) Profile

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Institutional Ownership by Quarter for Clorox Company (The) (NYSE:CLX)

Receive News & Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply